Entrar Registro gratuito

Akari Therapeutics Plc Venda descoberta % de circulação

Qual é o Venda descoberta % de circulação de Akari Therapeutics Plc?

O Venda descoberta % de circulação de Akari Therapeutics Plc é 0.00%

Qual é a definição de Venda descoberta % de circulação?



Porcentagem de venda de ações descobertas em circulação é a quantidade de ações que estão sendo vendidas descobertas comparada com a circulação de ações totais, expressa como uma porcentagem.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Venda descoberta % de circulação de empresas na Setor Health Care em NASDAQ em comparação com Akari Therapeutics Plc

O que Akari Therapeutics Plc faz?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Empresas com venda descoberta % de circulação semelhantes a Akari Therapeutics Plc